Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCGR | P47871 | 3/20 | 0.45 |
| ▸ | TERT | O14746 | 4/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.40 |
| ▸ | TOP1 | P11387 | 4/20 | 0.39 |
| ▸ | STAT3 | P40763 | 1/20 | 0.38 |
| ▸ | STAT1 | P42224 | 1/20 | 0.38 |
| ▸ | CYCS | P99999 | 2/20 | 0.37 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9231247 | 0.90 | TERT (0.48) | GCGRTERTDHFRTOP1STAT3 | |
| SCHEMBL29714914 | 0.84 | TOP1 (0.51) | TERTTOP1STAT3STAT1CYCS | |
| SCHEMBL27958995 | 0.84 | TOP1 (0.51) | TERTTOP1STAT3STAT1CYCS | |
| SCHEMBL8349653 | 0.84 | TOP1 (0.51) | TERTTOP1STAT3STAT1CYCS | |
| SCHEMBL28121945 | 0.84 | TOP1 (0.51) | TERTTOP1STAT3STAT1CYCS | |
| SCHEMBL10614661 | 0.83 | TOP1 (0.56) | GCGRTERTTOP1CYCSABCG2 | |
| SCHEMBL9388930 | 0.79 | TOP1 (0.50) | TERTTOP1STAT3STAT1CYCS | |
| SCHEMBL8198888 | 0.78 | TERT (0.46) | TERTTOP1STAT3CYCSABCG2 | |
| SCHEMBL6535064 | 0.78 | TERT (0.46) | GCGRTERTTOP1CYCSABCG2 | |
| SCHEMBL7261940 | 0.78 | TERT (0.38) | GCGRTERTTOP1STAT3STAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030203888-A1 | Chromophores | WELLCOME TRUST LIMITED, THE (GB) | 2003-10-30 | — | — | US | disclosed |
| EP-1294726-A2 | IMPROVEMENTS IN AND RELATING TO CHROMOPHORES | Catalyst Biomedica Ltd (GB) | 2003-03-26 | — | — | EP | disclosed |
| WO-2002000662-A1 | IMPROVEMENTS IN AND RELATING TO CHROMOPHORES | CATALYST BIOMEDICA LIMITED (GB) | 2002-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030203888-A1 | Chromophores | HCCS, PPOX, HMBS | GCGR 4586/4885TERT 3093/4885DHFR 113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.